Table 1.
Human MS brain tissues and sex- and age-matched control samples
| Group 1 (MS) |
Group 2 (control) |
||||||
|---|---|---|---|---|---|---|---|
| # | Sex | Age | Lesion | # | Sex | Age | Neuropath classifications |
| 1 | F | 42 | CL | 21 | F | 42 | No significant abnormalities |
| 2 | F | 53 | AL | 22 | F | 53 | No significant abnormalities |
| 3 | F | 53 | CL | 23 | F | 47 | No significant abnormalities |
| 4 | F | 44 | CL | 24 | F | 44 | No significant abnormalities |
| 5 | M | 46 | CAL | 25 | M | 46 | Control, vascular disease, other |
| 6 | F | 53 | AL/CAL | 26 | F | 51 | No significant abnormalities |
| 7 | M | 45 | CL | 27 | M | 45 | No significant abnormalities |
| 8 | F | 57 | CL | 28 | F | 57 | Depression, recurrent; dependence, alcohol; control, vascular disease, other |
| 9 | M | 43 | CAL | 29 | M | 43 | No significant abnormalities |
| 10 | F | 48 | CAL | 30 | F | 48 | No significant abnormalities |
| 11 | M | 45 | AL | 31 | M | 44 | No significant abnormalities |
| 12 | F | 71 | CAL | 32 | F | 71 | Control, vascular disease, other |
| 13 | F | 71 | AL/CAL | 33 | F | 71 | No significant abnormalities |
| 14 | F | 53 | CAL | 34 | F | 49 | No significant abnormalities |
| 15 | F | 42 | AL | 35 | F | 41 | No significant abnormalities |
| 16 | F | 50 | AL/CAL | 36 | F | 50 | Control, vascular disease, other |
| 17 | F | 44 | AL | 37 | F | 44 | No significant abnormalities |
| 18 | F | 50 | CAL | 38 | F | 51 | No significant abnormalities |
| 19 | F | 48 | AL/CAL | 39 | F | 49 | Control, substance abuse, alcohol; dependence, alcohol; no significant abnormalities |
| 20 | F | 57 | AL | 40 | F | 57 | No significant abnormalities |
AL, Active lesion; CAL, chronic active lesion; CL, chronic lesion.